Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




3D Nanodevice Detects Harmful Bacteria in Blood

By HospiMedica International staff writers
Posted on 09 Apr 2020
A new study describes how a nanofluidic three-dimensional (3D) device stacked with magnetic beads can trap, concentrate, and retrieve E. More...
coli from blood and plasma.

Developed at Rutgers University (Rutgers; Piscataway, NJ, USA), Tsinghua-UC Berkeley Shenzhen Institute (TBSI; China), the Rochester Institute of Technology (RIT; NY, USA), and other institutions, the inexpensive, transparent device is based on stacking magnetic beads with different sizes in order to create microscopic voids that can physically isolate bacteria. The sizes and ratio of the beads was calculated using computational fluid dynamics, 3D tomography technology, and machine learning, achieving a 86% capture efficiency with a flow rate of 50 μL/min.

By leveraging the high deformability of the device, E. coli samples can be retrieved from a bacterial suspension by applying a higher flow rate, followed by rapid magnetic separation. An on-chip 11-fold concentration factor can be achieved by inputting 1300 μL of the E. coli sample, and then concentrating it in 100 μL of buffer. The multiplexed, miniaturized, see-through device is easy to fabricate and operate, making it ideal for pathogen separation in both laboratory and in point-of-care (POC) settings. The study was published on January 15, 2020, in ACS Applied Materials & Interfaces.

“Drug-resistant bacteria have become a severe public health concern. Fortunately, this risk can be reduced via the correct use of prescriptions, and by avoiding unnecessary prescriptions, and over prescription of antibiotics,” concluded lead author Xinye Cen, PhD, of RIT, and colleagues. “In this regard, rapid isolation of the target bacteria from various samples is an essential step toward the identification of antibiotic resistance and providing early-treatment.”

Related Links:
Rutgers University
Tsinghua-UC Berkeley Shenzhen Institute
Rochester Institute of Technology



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.